The company had initiated a review of strategic options earlier this year. The penny stock jumped 21.77% to 17.9 cents in pre-market trading. Medical device maker Misonix, Inc. (NASDAQ: MSON)’s second …
The Daily Biotech Pulse: Mallinkckrodt’s Terlipressin, Deciphera Offering, Sellas Reboots On Earnings
The Daily Biotech Pulse: Mallinkckrodt’s Terlipressin, Deciphera Offering, Sellas Reboots On Earnings
Leave a reply